Hengrui Medicine (600276.SH): SHR-8068 injection, Adalimumab injection, and other drugs have been approved to conduct clinical trials.

Zhtng Cijng APP News, Hngru Yyo (600276.SH) issued an announcement recently. The company and its subsidiaries, Suzhou Shengdiya Biopharmaceutical Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd., recently received the Approval Notice for Clinical Trial of Drugs for SHR-8068 Injection, Atezolizumab Injection, and Bevacizumab Injection issued by the National Medical Products Administration. Clinical trials will be conducted in the near future.